Kaiser just contacted me and wants me to come in for a course of treatment with Evushield ( which is Tixagevimab and Cilgavimab ) , which is being prescribed for me by “ emergency use authorization “ because it’s not approved for my application in the USA …
I don’t think I’ve ever heard of this drug / treatment on the group before , might have missed it. Plus this kind of attention seems somewhat out of the ordinary, from Kaiser. Anyone know about this drug being used , investigational , related to PCa or maybe this is just trying to bolster my immune system against bugs like the flu or Covid. I know nothing about monoclonal antibodies , or why Kaiser might doing this ….. any thoughts, contradictions or ???
preciate it ❤️❤️❤️
For immune-compromised people against Covid-19:
fda.gov/news-events/press-a...
Kewl thanks TA …